Ex-Biopharma CEO Sues For Post-Sale Share Appraisal In Del.
Law 360
MARCH 12, 2024
The co-founder of Caraway Therapeutics Inc. sued in Delaware's Court of Chancery on Tuesday for an appraisal of his shares following the company's November merger with a subsidiary of pharmaceutical giant Merck, alleging that it "was an unfair cash-out transaction" and that he is owed at least a million more shares.
Let's personalize your content